Cargando…
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has been discussed in the context of Parkinson’s disease (PD) over the last three years. Now that we are entering the long-term phase of this pandemic, we are intrigued to look back and se...
Autores principales: | Boura, Iro, Qamar, Mubasher A., Daddoveri, Francesco, Leta, Valentina, Poplawska-Domaszewicz, Karolina, Falup-Pecurariu, Cristian, Ray Chaudhuri, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526287/ https://www.ncbi.nlm.nih.gov/pubmed/37760965 http://dx.doi.org/10.3390/biomedicines11092524 |
Ejemplares similares
-
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022) -
The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need
por: Chaudhuri, Kallol Ray, et al.
Publicado: (2022) -
Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017) -
Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023) -
Dry eye in Parkinson's disease: a narrative review
por: Ungureanu, Larisa, et al.
Publicado: (2023)